oncology Articles
Abbott Laboratories and Progenics to Cut Jobs
Thursday, September 15th, 2011 by Cliffprf Mintz
Abbott Laboratories today announced it is eliminating 160 jobs in an attempt to shore up its diagnostics business.Most of the job cuts 150 will take place at the companys Santa Clara, CA production facility. The remaining jobs will be eliminated at Abbotts North Chicago corporate... Read more
The Cannabis Genome Is Sequenced
Monday, August 22nd, 2011 by Cliffprf Mintz
A Massachusetts start up company called Medicinal Genomics announced late last week that it had sequenced the cannabis genome. Kevin McKernan the head of Medicinal Genomics and former leader of Life Technologies Corp Ion Torrent DNA-sequence program decided to undertake the proje... Read more
More M&A in the Life Sciences Sector: Valeant Pharmaceuticals Attempts Hostile Takeover of Cephalon
Wednesday, March 30th, 2011 by Cliffprf Mintz
It seems like hostile takeover bids in the life sciences industry may be de rigueur how can anyone forget the Sanofi-AventisGenzyme hostile takeover saga that dragged on for almost a year. Interestingly, there have been 219 acquisitions of U.S. pharmaceutical companies in the pas... Read more
At Long Last: Sanofi and Genzyme May Be Close to a Deal!
Tuesday, February 1st, 2011 by Cliffprf Mintz
After a five month-long series of very public and often acrimonious negotiations, it appears that Sanofi-Aventis and Genzyme may be close to deal that would enable the French drug maker to acquire one of the worlds largest public biotechnology companies. According to the NY Times... Read more
What Ever Happened to Amgen?
Tuesday, January 25th, 2011 by Cliffprf Mintz
Five years ago Amgen was the worlds largest biotechnology and was, by many accounts, the darling of Wall Street. But, today, there is little mention of the once formidable biotechnology company that many startups attempted to emulate.Like other companies, Amgen ran into pipeline ... Read more
Sanofi-Aventis' Oncology Push
Friday, December 17th, 2010 by Cliffprf Mintz
It is no secret that Sanofi-Aventis is facing a steep patent cliff in 2013 when some of its top selling drugs, most notably Plavix, will lose patent protection. Some analysts contend that the company can lose as much as a quarter of its annual revenue because of generic encroachm... Read more
Mirror, Mirror on the Wall Who's the Most Ambitious Big Pharma Company of Them All?
Saturday, December 11th, 2010 by Cliffprf Mintz
Since I dont have a magic mirror, I can only go on what I read in the Internet.And, it appears that Roche may be the most ambitious pharma company of them all; at least by 2013. According to a post on PharmLive, Roches late-stage pipeline is progressing well with potentially ten ... Read more
A Novel Alternate Career Choice
Wednesday, September 8th, 2010 by Cliffprf Mintz
Several years ago a television show appeared on the BBC entitled Secret Diary of a Call Girl which follows the life of a seemingly ordinary, but struggling, student named Hannah aka Belle de Jour who, unbeknownst to family and friends, secretly moonlights as a prostitute to make ... Read more
Obesity and Cancer Risk
Monday, July 26th, 2010 by Dr. Robert Wascher
OBESITY AND CANCER RISK We have become the heaviest people in the history of our species, with two-thirds of Americans officially classified as overweight, and one of every three of us tipping the scales into the obese range. For too many ... Read more
Diacylglycerol (Diglyceride) Cooking Oil Reduces Obesity
Sunday, June 13th, 2010 by Dr. Robert Wascher
DIACYLGLYCEROL DIGLYCERIDE COOKING OIL REDUCES OBESITY Diacylglycerols also known as diglycerides are dietary fatty acids that are found, in small concentrations, in many vegetable-based cooking oils, including canola and soybean oils. However, triacylglycerols, known more common... Read more
Goto page 123